Natus Medical Inc (BABY) : Beddow Capital Management Inc scooped up 25,735 additional shares in Natus Medical Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 11, 2016. The investment management firm now holds a total of 174,750 shares of Natus Medical Inc which is valued at $6,785,543.Natus Medical Inc makes up approximately 2.57% of Beddow Capital Management Inc’s portfolio.
Other Hedge Funds, Including , Teacher Retirement System Of Texas boosted its stake in BABY in the latest quarter, The investment management firm added 562 additional shares and now holds a total of 4,602 shares of Natus Medical Inc which is valued at $175,014.Victory Capital Management Inc boosted its stake in BABY in the latest quarter, The investment management firm added 850 additional shares and now holds a total of 1,948 shares of Natus Medical Inc which is valued at $74,803. Capital One National Association sold out all of its stake in BABY during the most recent quarter. The investment firm sold 9,673 shares of BABY which is valued $381,793.
Natus Medical Inc opened for trading at $38.77 and hit $39.222 on the upside on Tuesday, eventually ending the session at $39.05, with a gain of 0.85% or 0.33 points. The heightened volatility saw the trading volume jump to 1,18,673 shares. Company has a market cap of $1,287 M.
On the company’s financial health, Natus Medical Inc reported $0.39 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.36. The company had revenue of $96.00 million for the quarter, compared to analysts expectations of $92.71 million. The company’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.34 EPS.
Natus Medical Incorporated (Natus) is a provider of newborn care and neurology healthcare products and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders and balance and mobility disorders. The Company offers two product families: Neurology which includes products and services for diagnostic electroencephalography and long term monitoring intensive care unit monitoring electromyography sleep analysis intra-operative monitoring and diagnostic and monitoring transcranial doppler ultrasound technology; and Newborn Care which includes products and services for newborn care including hearing screening brain injury thermoregulation jaundice management and various disposable products as well as products for diagnostic hearing assessment for children through adult populations and others.